Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis

NCT02466243 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor terminated open-label extension.

Conditions

Dermatomyositis

Interventions

DRUG: JBT-101
DRUG: Placebo

Sponsor

Corbus Pharmaceuticals Inc.

Collaborators

[object Object]
[object Object]